Pyrvinium Pamoate
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Pyrvinium Pamoate, covering 2025-07-15 to 2025-07-15. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Determine if the Drug, Pyrvinium Pamoate, is Safe and Tolerable in Patients With Pancreatic Cancer [Phase 1]